Omers Administration Corp Ionis Pharmaceuticals Inc Transaction History

Omers Administration Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 08, 2019	SELL	$62.09 - $86.14 $1.58 Million - $2.19 Million	-25,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $1.34 Million - $2.06 Million	25,400 New	25,400 $2.14 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

Stay updated on Omers Administration Corp with notifications on news.